---
title: "Top 10 US Stock Gainers (2.24)"
description: "Clarivate(CLVT) rose 39.88%, with a trading turnover 100.0 Million USD, and a year-to-date fell 29.6%. Palvella Therapeutics(PVLA) rose 37.08%, with a trading turnover 140.8 Million USD, and a year-to"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/276793214.md"
published_at: "2026-02-24T22:01:02.000Z"
---

# Top 10 US Stock Gainers (2.24)

> Clarivate(CLVT) rose 39.88%, with a trading turnover 100.0 Million USD, and a year-to-date fell 29.6%. Palvella Therapeutics(PVLA) rose 37.08%, with a trading turnover 140.8 Million USD, and a year-to-date rose 15%. Iovance Biotherapeautics(IOVA) rose 30.8%, with a trading turnover 254.1 Million USD, and a year-to-date rose 38.5%.

NASDAQ Composite Index has rose 1.04%, with a year-to-date fell 1.6%; S&P 500 has rose 0.77%, with a year-to-date rose 0.7%; Dow Jones Industrial Average has rose 0.76%, with a year-to-date rose 2.3%.

Clarivate(CLVT) rose 39.88%, with a trading turnover 100.0 Million USD, and a year-to-date fell 29.6%.

Palvella Therapeutics(PVLA) rose 37.08%, with a trading turnover 140.8 Million USD, and a year-to-date rose 15%.

Iovance Biotherapeautics(IOVA) rose 30.8%, with a trading turnover 254.1 Million USD, and a year-to-date rose 38.5%.

### Related Stocks

- [CLVT.US - Clarivate](https://longbridge.com/en/quote/CLVT.US.md)
- [PVLA.US - Palvella Therapeutics](https://longbridge.com/en/quote/PVLA.US.md)
- [IOVA.US - Iovance Biotherapeautics](https://longbridge.com/en/quote/IOVA.US.md)
- [VIR.US - Vir Biotechnology](https://longbridge.com/en/quote/VIR.US.md)
- [AXTI.US - AXT](https://longbridge.com/en/quote/AXTI.US.md)
- [KEYS.US - Keysight Tech](https://longbridge.com/en/quote/KEYS.US.md)
- [IBRX.US - ImmunityBio](https://longbridge.com/en/quote/IBRX.US.md)
- [UCTT.US - Ultra Clean](https://longbridge.com/en/quote/UCTT.US.md)
- [GRAL.US - GRAIL](https://longbridge.com/en/quote/GRAL.US.md)
- [HLX.US - Helix Energy Solutions](https://longbridge.com/en/quote/HLX.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Are Wall Street Analysts Predicting Keysight Technologies Stock Will Climb or Sink? | Are Wall Street Analysts Predicting Keysight Technologies Stock Will Climb or Sink? | [Link](https://longbridge.com/en/news/276353077.md) |
| Palvella Therapeutics (PVLA) Surges On Positive Phase 3 QTORIN SELVA Data | Palvella Therapeutics (NASDAQ:PVLA) shares surged 33.23% to $118.01 following positive topline data from its Phase 3 SEL | [Link](https://longbridge.com/en/news/276758655.md) |
| Iovance Biotherapeutics: Strengthening Commercial Momentum and Expanding Amtagvi Runway Support Buy Rating | TD Cowen analyst Tyler Van Buren has maintained a Buy rating on Iovance Biotherapeutics (IOVA), citing strong commercial | [Link](https://longbridge.com/en/news/276776997.md) |
| NEOS Investment Management LLC Raises Stake in Keysight Technologies Inc. $KEYS | NEOS Investment Management LLC increased its stake in Keysight Technologies Inc. by 44.3% in Q3, now holding 18,730 shar | [Link](https://longbridge.com/en/news/276440516.md) |
| IOVANCE BIOTHERAPEUTICS, INC. SEC 10-K Report | Iovance Biotherapeutics, Inc. has released its 2025 Form 10-K report, highlighting a total product revenue of $263.5 mil | [Link](https://longbridge.com/en/news/276753711.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.